Page last updated: 2024-09-05

sorafenib and orlistat

sorafenib has been researched along with orlistat in 3 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(orlistat)
Trials
(orlistat)
Recent Studies (post-2010) (orlistat)
6,5207305,2511,432274539

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)orlistat (IC50)
Phosphatidylserine lipase ABHD16AHomo sapiens (human)0.1
Pancreatic triacylglycerol lipaseSus scrofa (pig)0.4214
Lipoprotein lipaseHomo sapiens (human)0.066
Cytochrome P450 3A4Homo sapiens (human)0.42
Hepatic triacylglycerol lipaseHomo sapiens (human)0.003
Pancreatic triacylglycerol lipaseHomo sapiens (human)0.3253
Translocator proteinRattus norvegicus (Norway rat)1
Cytochrome P450 2C19Homo sapiens (human)0.42
Kappa-type opioid receptorMus musculus (house mouse)0.1903
Fatty acid synthaseHomo sapiens (human)2.99
Fatty-acid amide hydrolase 1Rattus norvegicus (Norway rat)0.01
Platelet-activating factor acetylhydrolaseHomo sapiens (human)0.05
Diacylglycerol lipase-alphaMus musculus (house mouse)0.02
Lysophosphatidylserine lipase ABHD12Homo sapiens (human)0.1682
Diacylglycerol lipase-betaHomo sapiens (human)0.24
Monoacylglycerol lipase ABHD6Homo sapiens (human)0.03
Acyl-protein thioesterase 2Rattus norvegicus (Norway rat)0.17
Diacylglycerol lipase-alphaHomo sapiens (human)0.2677
Endothelial lipaseHomo sapiens (human)0.006

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Chen, J; Chen, T; Cui, Y; Ge, C; Geng, Q; Jin, W; Li, H; Li, J; Lin, H; Liu, T; Miao, C; Tian, H; Xiao, X; Xie, H; Yao, M; Yu, J; Zhao, F; Zhou, Q1
Cheng, Z; Dai, W; Feng, J; Guo, C; Ji, J; Li, J; Li, Y; Wu, J; Wu, L; Xu, X; Yang, M; Yang, W; Zhang, J; Zheng, Y1

Reviews

1 review(s) available for sorafenib and orlistat

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

2 other study(ies) available for sorafenib and orlistat

ArticleYear
Sperm associated antigen 4 promotes SREBP1-mediated de novo lipogenesis via interaction with lamin A/C and contributes to tumor progression in hepatocellular carcinoma.
    Cancer letters, 2022, 06-28, Volume: 536

    Topics: Animals; Carcinogenesis; Carcinoma, Hepatocellular; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Lamin Type A; Lipogenesis; Liver Neoplasms; Mice; Orlistat; Sorafenib; Sterol Regulatory Element Binding Protein 1

2022
Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis.
    Journal of experimental & clinical cancer research : CR, 2023, Jan-06, Volume: 42, Issue:1

    Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Neoplasm; Fatty Acid Synthases; Ferroptosis; Humans; Liver Neoplasms; Orlistat; Sorafenib

2023